タンパク質配列決定のヨーロッパ市場2020-2164

◆英語タイトル:EUROPE PROTEIN SEQUENCING MARKET FORECAST 2020-2028
◆商品コード:INK20MY215
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年3月
◆ページ数:90
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:ヨーロッパ
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥131,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥210,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGS The Europe protein sequencing market is anticipated to register a CAGR of 6.29% over the estimated period of 2020-2028. The high growth potential of the European market owing to the ongoing developments in the next-generation sequencing techniques. Data analysis software, R&D and technological innovation of the sequencing platforms, application of cloud computing to stire data, and data storage and management are the factors fueling the market growth in the region.

MARKET INSIGHTS
The growth of the European market of protein sequencing is studied on the basis of the markets situated in the countries in the region such as Italy, Russia, Poland, Germany, Belgium, France, the UK, and the rest of Europe that includes Denmark, Netherlands, Spain, Sweden, and others. The Russian market is showcasing growth due to the improving biotech and healthcare industries. The state initiatives have given a strong drive to establish new manufacturing facilities in the country. The new factory opened by R-Pharm will support the production of Biosimilars and biologics focused on treating cancer and autoimmune diseases. In Belgium, the market is flourishing due to the presence of high quality research institutes. In addition, biopharma organizations are manufacturing and developing assets and operating on a global scale.
In Poland, the dynamic growth of the domestic biotechnological market owing to innovative research projects carried out by academic institutions and the biotech companies, as well as by the foreign investments pouring into the biotech sector, the protein sequencing market is witnessing an emerging growth. Additionally, Poland is becoming the epicenter for biotech startups and pharmaceutical companies. The Netherlands has an extraordinary reputation in medicine. Many multinational companies are investing in Holland as the country is at the forefront of biopharmaceutical research and technology.

COMPETITIVE INSIGHTS
Agilent Technologies, Inc, SGS SA, Proteome factory, Selvita, Shimadzu Corporation, etc. are some of the leading companies operating in the region.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with three years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. GROWING FOCUS ON TARGET-BASED DRUG DEVELOPMENT
3.2.2. DEVELOPMENTS IN MASS SPECTROMETRY AND ANALYTICAL TECHNIQUES
3.2.3. ADVANCES IN COMPUTATIONAL PROTEOMICS
3.3. KEY RESTRAINTS
3.3.1. SHORTAGE OF TRAINED RESEARCHERS AND LABORATORY PROFESSIONALS
3.3.2. EXORBITANT COST LEVIED BY INFRASTRUCTURE
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
5. MARKET BY PRODUCT AND SERVICE
5.1. REAGENTS AND CONSUMABLES
5.2. INSTRUMENTS
5.2.1. EDMAN DEGRADATION
5.2.2. MASS SPECTROMETRY
5.3. ANALYSIS PRODUCT
5.4. PROTEIN SEQUENCING SERVICES
6. MARKET BY TECHNOLOGY
6.1. MASS SPECTROMETRY
6.2. EDMAN DEGRADATION
7. MARKET BY APPLICATION
7.1. ACADEMIA
7.2. BIOPHARMACEUTICALS
7.3. BIOTECHNOLOGY RESEARCH
8. GEOGRAPHICAL ANALYSIS
8.1. EUROPE
8.1.1. UNITED KINGDOM
8.1.2. GERMANY
8.1.3. FRANCE
8.1.4. ITALY
8.1.5. RUSSIA
8.1.6. BELGIUM
8.1.7. POLAND
8.1.8. REST OF EUROPE
9. COMPANY PROFILES
9.1. SHIMADZU CORPORATION
9.2. AGILENT TECHNOLOGIES INC
9.3. THERMOFISHER SCIENTIFIC INC
9.4. PROTEOME FACTORY
9.5. WATER CORPORATION
9.6. BIOINFORMATICS SOLUTION
9.7. CHARLES RIVER LABORATORIES INC
9.8. SELVITA
9.9. RAPID NOVOR
9.10. SGS SA
9.11. BRUKER CORPORATION
9.12. TAKARA BIO



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[タンパク質配列決定のヨーロッパ市場2020-2164]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆